Biotech: Steak, But No Sizzle

The earnings season for Big Biotech kicks of later this month when Biogen ( BIIB ) unveils second quarter financial results on July 21. But will those reports be enough to reverse the negative sentiment surrounding the sector?
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.